已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Differentiation therapy of myeloid leukemia: four decades of development

髓系白血病 急性早幼粒细胞白血病 分化疗法 医学 髓样 白血病 临床试验 癌症研究 维甲酸 免疫学 生物 内科学 细胞培养 遗传学
作者
Vikas Madan,Harold Phillip Koeffler
出处
期刊:Haematologica [Ferrata Storti Foundation]
卷期号:106 (1): 26-38 被引量:94
标识
DOI:10.3324/haematol.2020.262121
摘要

Acute myeloid leukemia is characterized by arrested differentiation, and agents that overcome this block are therapeutically useful, as shown by the efficacy of all-trans retinoic acid in acute promyelocytic leukemia. However, the early promise of differentiation therapy did not translate into clinical benefit for other subtypes of acute myeloid leukemia, in which cytotoxic chemotherapeutic regimens remained the standard of care. Recent advances, including insights from sequencing of acute myeloid leukemia genomes, have led to the development of targeted therapies, comprising agents that induce differentiation of leukemic cells in preclinical models and clinical trials, thus rejuvenating interest in differentiation therapy. These agents act on various cellular processes including dysregulated metabolic programs, signaling pathways, epigenetic machinery and the cell cycle. In particular, inhibitors of mutant IDH1/2 and FLT3 have shown clinical benefit, leading to approval by regulatory bodies of their use. Besides the focus on recently approved differentiation therapies, this review also provides an overview of differentiation- inducing agents being tested in clinical trials or investigated in preclinical research. Combinatorial strategies are currently being tested for several agents (inhibitors of KDM1A, DOT1L, BET proteins, histone deacetylases), which were not effective in clinical studies as single agents, despite encouraging anti-leukemic activity observed in preclinical models. Overall, recently approved drugs and new investigational agents being developed highlight the merits of differentiation therapy; and ongoing studies promise further advances in the treatment of acute myeloid leukemia in the near future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
TX完成签到,获得积分10
3秒前
3秒前
4秒前
朴实无招完成签到,获得积分10
6秒前
TTTTT完成签到 ,获得积分10
6秒前
李爱国的应助被DW采纳,获得10
7秒前
8秒前
Leung完成签到,获得积分10
8秒前
dd完成签到 ,获得积分10
8秒前
饱饱发布了新的文献求助10
9秒前
jcz的应助被ernest采纳,获得150
9秒前
10秒前
URB7完成签到,获得积分10
10秒前
刻苦乐天完成签到,获得积分10
11秒前
顺心惜文完成签到 ,获得积分10
11秒前
12秒前
13秒前
milk完成签到 ,获得积分10
15秒前
传奇3的应助被数智采纳,获得10
16秒前
Danny完成签到,获得积分10
16秒前
16秒前
18秒前
lujibaqi发布了新的文献求助10
18秒前
忘忧草完成签到 ,获得积分10
18秒前
Anserbe完成签到 ,获得积分10
18秒前
19秒前
It完成签到 ,获得积分10
19秒前
GingerF的应助被DW采纳,获得50
19秒前
sss完成签到,获得积分20
23秒前
23秒前
夏目完成签到,获得积分10
24秒前
谦让夏山完成签到 ,获得积分10
24秒前
土豆豆完成签到 ,获得积分10
25秒前
兴奋枫完成签到,获得积分10
25秒前
gmy发布了新的文献求助10
25秒前
小正完成签到,获得积分10
26秒前
yueqi完成签到,获得积分10
27秒前
一口一完成签到 ,获得积分10
28秒前
yingying完成签到 ,获得积分10
29秒前
WYT发布了新的文献求助10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184828
求助须知:如何正确求助?哪些是违规求助? 9573791
关于积分的说明 21833034
捐赠科研通 7782127
什么是DOI,文献DOI怎么找? 3434405
关于科研通互助平台的介绍 2558545
邀请新用户注册赠送积分活动 2481067